TickerFacts.

Theriva Biologics, Inc. (TOVX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-35, first reflected in a filing dated 2018-11-08; 1-for-10, first reflected in a filing dated 2022-08-11; 1-for-25, first reflected in a filing dated 2024-11-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

12.14M
Year ended 2025-12-31
19.01M2020-12-31: 19.01M2021-12-31: 12.19M2022-12-31: 15.33M2023-12-31: 644.3K2024-12-31: 1.35M2025-12-31: 12.14M12.14M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3112.14M+800.6%2026-03-12, From 2025-01-01
2024-12-311.35Mn/c2026-03-12, From 2024-01-01
2023-12-31644.3Kn/c2025-03-06, From 2023-01-01
2022-12-3115.33M+25.8%2024-03-25, From 2022-01-01
2021-12-3112.19Mn/c2023-03-30, From 2021-01-01
2020-12-3119.01Mn/a2022-03-16, From 2020-01-01